Table of Content

1 Radiopharmaceutical Market Overview
1.1 Product Overview and Scope of Radiopharmaceutical
1.2 Radiopharmaceutical Segment by Type
1.2.1 Global Radiopharmaceutical Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Radiopharmaceutical Segment by Application
1.3.1 Global Radiopharmaceutical Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceutical Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceutical Revenue 2016-2027
1.4.2 Global Radiopharmaceutical Sales 2016-2027
1.4.3 Radiopharmaceutical Market Size by Region: 2016 Versus 2021 Versus 2027

2 Radiopharmaceutical Market Competition by Manufacturers
2.1 Global Radiopharmaceutical Sales Market Share by Manufacturers (2016-2021)
2.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Radiopharmaceutical Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Radiopharmaceutical Manufacturing Sites, Area Served, Product Type
2.5 Radiopharmaceutical Market Competitive Situation and Trends
2.5.1 Radiopharmaceutical Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Radiopharmaceutical Players Market Share by Revenue
2.5.3 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Radiopharmaceutical Retrospective Market Scenario by Region
3.1 Global Radiopharmaceutical Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Radiopharmaceutical Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Radiopharmaceutical Market Facts & Figures by Country
3.3.1 North America Radiopharmaceutical Sales by Country
3.3.2 North America Radiopharmaceutical Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Radiopharmaceutical Market Facts & Figures by Country
3.4.1 Europe Radiopharmaceutical Sales by Country
3.4.2 Europe Radiopharmaceutical Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Radiopharmaceutical Market Facts & Figures by Region
3.5.1 Asia Pacific Radiopharmaceutical Sales by Region
3.5.2 Asia Pacific Radiopharmaceutical Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Radiopharmaceutical Market Facts & Figures by Country
3.6.1 Latin America Radiopharmaceutical Sales by Country
3.6.2 Latin America Radiopharmaceutical Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country
3.7.1 Middle East and Africa Radiopharmaceutical Sales by Country
3.7.2 Middle East and Africa Radiopharmaceutical Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Radiopharmaceutical Historic Market Analysis by Type
4.1 Global Radiopharmaceutical Sales Market Share by Type (2016-2021)
4.2 Global Radiopharmaceutical Revenue Market Share by Type (2016-2021)
4.3 Global Radiopharmaceutical Price by Type (2016-2021)

5 Global Radiopharmaceutical Historic Market Analysis by Application
5.1 Global Radiopharmaceutical Sales Market Share by Application (2016-2021)
5.2 Global Radiopharmaceutical Revenue Market Share by Application (2016-2021)
5.3 Global Radiopharmaceutical Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Bracco Imaging
6.1.1 Bracco Imaging Corporation Information
6.1.2 Bracco Imaging Description and Business Overview
6.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Bracco Imaging Radiopharmaceutical Product Portfolio
6.1.5 Bracco Imaging Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bayer Radiopharmaceutical Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Mallinckrodt
6.3.1 Mallinckrodt Corporation Information
6.3.2 Mallinckrodt Description and Business Overview
6.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mallinckrodt Radiopharmaceutical Product Portfolio
6.3.5 Mallinckrodt Recent Developments/Updates
6.4 Nordion
6.4.1 Nordion Corporation Information
6.4.2 Nordion Description and Business Overview
6.4.3 Nordion Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nordion Radiopharmaceutical Product Portfolio
6.4.5 Nordion Recent Developments/Updates
6.5 Triad Isotopes
6.5.1 Triad Isotopes Corporation Information
6.5.2 Triad Isotopes Description and Business Overview
6.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Triad Isotopes Radiopharmaceutical Product Portfolio
6.5.5 Triad Isotopes Recent Developments/Updates
6.6 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Lantheus Radiopharmaceutical Product Portfolio
6.6.5 Lantheus Recent Developments/Updates
6.7 IBA Group
6.6.1 IBA Group Corporation Information
6.6.2 IBA Group Description and Business Overview
6.6.3 IBA Group Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.4.4 IBA Group Radiopharmaceutical Product Portfolio
6.7.5 IBA Group Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.8.4 GE Healthcare Radiopharmaceutical Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Corporation Information
6.9.2 China Isotope & Radiation Description and Business Overview
6.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.9.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio
6.9.5 China Isotope & Radiation Recent Developments/Updates
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Corporation Information
6.10.2 Jubilant Pharma Description and Business Overview
6.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Jubilant Pharma Radiopharmaceutical Product Portfolio
6.10.5 Jubilant Pharma Recent Developments/Updates
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Radiopharmaceutical Description and Business Overview
6.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Eli Lilly Radiopharmaceutical Product Portfolio
6.11.5 Eli Lilly Recent Developments/Updates
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Corporation Information
6.12.2 Advanced Accelerator Applications Radiopharmaceutical Description and Business Overview
6.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Portfolio
6.12.5 Advanced Accelerator Applications Recent Developments/Updates
6.13 SIEMENS
6.13.1 SIEMENS Corporation Information
6.13.2 SIEMENS Radiopharmaceutical Description and Business Overview
6.13.3 SIEMENS Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.13.4 SIEMENS Radiopharmaceutical Product Portfolio
6.13.5 SIEMENS Recent Developments/Updates
6.14 Dongcheng
6.14.1 Dongcheng Corporation Information
6.14.2 Dongcheng Radiopharmaceutical Description and Business Overview
6.14.3 Dongcheng Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Dongcheng Radiopharmaceutical Product Portfolio
6.14.5 Dongcheng Recent Developments/Updates
6.15 Navidea
6.15.1 Navidea Corporation Information
6.15.2 Navidea Radiopharmaceutical Description and Business Overview
6.15.3 Navidea Radiopharmaceutical Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Navidea Radiopharmaceutical Product Portfolio
6.15.5 Navidea Recent Developments/Updates

7 Radiopharmaceutical Manufacturing Cost Analysis
7.1 Radiopharmaceutical Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Radiopharmaceutical
7.4 Radiopharmaceutical Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Radiopharmaceutical Distributors List
8.3 Radiopharmaceutical Customers

9 Radiopharmaceutical Market Dynamics
9.1 Radiopharmaceutical Industry Trends
9.2 Radiopharmaceutical Growth Drivers
9.3 Radiopharmaceutical Market Challenges
9.4 Radiopharmaceutical Market Restraints

10 Global Market Forecast
10.1 Radiopharmaceutical Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Radiopharmaceutical by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Radiopharmaceutical by Type (2022-2027)
10.2 Radiopharmaceutical Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Radiopharmaceutical by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Radiopharmaceutical by Application (2022-2027)
10.3 Radiopharmaceutical Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Radiopharmaceutical by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Radiopharmaceutical by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Radiopharmaceutical Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Radiopharmaceutical Sales (M Doses) Comparison by Application (2021-2027)
Table 3. Global Radiopharmaceutical Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Radiopharmaceutical Covered in This Study
Table 5. Global Radiopharmaceutical Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global Radiopharmaceutical Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Radiopharmaceutical Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Radiopharmaceutical Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Radiopharmaceutical Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Radiopharmaceutical Manufacturing Sites and Area Served
Table 11. Manufacturers Radiopharmaceutical Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceutical as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Radiopharmaceutical Sales by Region (2016-2021) & (M Doses)
Table 16. Global Radiopharmaceutical Sales Market Share by Region (2016-2021)
Table 17. Global Radiopharmaceutical Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 19. North America Radiopharmaceutical Sales Market Share by Country (2016-2021)
Table 20. North America Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Radiopharmaceutical Revenue Market Share by Country (2016-2021)
Table 22. Europe Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 23. Europe Radiopharmaceutical Sales Market Share by Country (2016-2021)
Table 24. Europe Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Radiopharmaceutical Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Radiopharmaceutical Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific Radiopharmaceutical Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Radiopharmaceutical Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Radiopharmaceutical Revenue Market Share by Region (2016-2021)
Table 30. Latin America Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America Radiopharmaceutical Sales Market Share by Country (2016-2021)
Table 32. Latin America Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Radiopharmaceutical Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Radiopharmaceutical Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Radiopharmaceutical Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country (2016-2021)
Table 38. Global Radiopharmaceutical Sales (M Doses) by Type (2016-2021)
Table 39. Global Radiopharmaceutical Sales Market Share by Type (2016-2021)
Table 40. Global Radiopharmaceutical Revenue (Million US$) by Type (2016-2021)
Table 41. Global Radiopharmaceutical Revenue Share by Type (2016-2021)
Table 42. Global Radiopharmaceutical Price (USD/Dose) by Type (2016-2021)
Table 43. Global Radiopharmaceutical Sales (M Doses) by Application (2016-2021)
Table 44. Global Radiopharmaceutical Sales Market Share by Application (2016-2021)
Table 45. Global Radiopharmaceutical Revenue (Million US$) by Application (2016-2021)
Table 46. Global Radiopharmaceutical Revenue Share by Application (2016-2021)
Table 47. Global Radiopharmaceutical Price (USD/Dose) by Application (2016-2021)
Table 48. Bracco Imaging Corporation Information
Table 49. Bracco Imaging Description and Business Overview
Table 50. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Bracco Imaging Radiopharmaceutical Product
Table 52. Bracco Imaging Recent Developments/Updates
Table 53. Bayer Corporation Information
Table 54. Bayer Description and Business Overview
Table 55. Bayer Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Bayer Radiopharmaceutical Product
Table 57. Bayer Recent Developments/Updates
Table 58. Mallinckrodt Corporation Information
Table 59. Mallinckrodt Description and Business Overview
Table 60. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Mallinckrodt Radiopharmaceutical Product
Table 62. Mallinckrodt Recent Developments/Updates
Table 63. Nordion Corporation Information
Table 64. Nordion Description and Business Overview
Table 65. Nordion Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Nordion Radiopharmaceutical Product
Table 67. Nordion Recent Developments/Updates
Table 68. Triad Isotopes Corporation Information
Table 69. Triad Isotopes Description and Business Overview
Table 70. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Triad Isotopes Radiopharmaceutical Product
Table 72. Triad Isotopes Recent Developments/Updates
Table 73. Lantheus Corporation Information
Table 74. Lantheus Description and Business Overview
Table 75. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Lantheus Radiopharmaceutical Product
Table 77. Lantheus Recent Developments/Updates
Table 78. IBA Group Corporation Information
Table 79. IBA Group Description and Business Overview
Table 80. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. IBA Group Radiopharmaceutical Product
Table 82. IBA Group Recent Developments/Updates
Table 83. GE Healthcare Corporation Information
Table 84. GE Healthcare Description and Business Overview
Table 85. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. GE Healthcare Radiopharmaceutical Product
Table 87. GE Healthcare Recent Developments/Updates
Table 88. China Isotope & Radiation Corporation Information
Table 89. China Isotope & Radiation Description and Business Overview
Table 90. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. China Isotope & Radiation Radiopharmaceutical Product
Table 92. China Isotope & Radiation Recent Developments/Updates
Table 93. Jubilant Pharma Corporation Information
Table 94. Jubilant Pharma Description and Business Overview
Table 95. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. Jubilant Pharma Radiopharmaceutical Product
Table 97. Jubilant Pharma Recent Developments/Updates
Table 98. Eli Lilly Corporation Information
Table 99. Eli Lilly Description and Business Overview
Table 100. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 101. Eli Lilly Radiopharmaceutical Product
Table 102. Eli Lilly Recent Developments/Updates
Table 103. Advanced Accelerator Applications Corporation Information
Table 104. Advanced Accelerator Applications Description and Business Overview
Table 105. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 106. Advanced Accelerator Applications Radiopharmaceutical Product
Table 107. Advanced Accelerator Applications Recent Developments/Updates
Table 108. SIEMENS Corporation Information
Table 109. SIEMENS Description and Business Overview
Table 110. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 111. SIEMENS Radiopharmaceutical Product
Table 112. SIEMENS Recent Developments/Updates
Table 113. Dongcheng Corporation Information
Table 114. Dongcheng Description and Business Overview
Table 115. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 116. Dongcheng Radiopharmaceutical Product
Table 117. Dongcheng Recent Developments/Updates
Table 118. Navidea Corporation Information
Table 119. Navidea Description and Business Overview
Table 120. Navidea Radiopharmaceutical Sales (M Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 121. Navidea Radiopharmaceutical Product
Table 122. Navidea Recent Developments/Updates
Table 123. Production Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Radiopharmaceutical Distributors List
Table 126. Radiopharmaceutical Customers List
Table 127. Radiopharmaceutical Market Trends
Table 128. Radiopharmaceutical Growth Drivers
Table 129. Radiopharmaceutical Market Challenges
Table 130. Radiopharmaceutical Market Restraints
Table 131. Global Radiopharmaceutical Sales Forecast by Type (2022-2027) & (M Doses)
Table 132. Global Radiopharmaceutical Sales Market Share Forecast by Type (2022-2027)
Table 133. Global Radiopharmaceutical Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 134. Global Radiopharmaceutical Revenue Market Share Forecast by Type (2022-2027)
Table 135. Global Radiopharmaceutical Sales Forecast by Application (2022-2027) & (M Doses)
Table 136. Global Radiopharmaceutical Sales Market Share Forecast by Application (2022-2027)
Table 137. Global Radiopharmaceutical Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 138. Global Radiopharmaceutical Revenue Market Share Forecast by Application (2022-2027)
Table 139. Global Radiopharmaceutical Sales Forecast by Region (2022-2027) & (M Doses)
Table 140. Global Radiopharmaceutical Sales Market Share Forecast by Region (2022-2027)
Table 141. Global Radiopharmaceutical Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 142. Global Radiopharmaceutical Revenue Market Share Forecast by Region (2022-2027)
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Radiopharmaceutical
Figure 2. Global Radiopharmaceutical Market Share by Type in 2020 & 2027
Figure 3. Actinium-225 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Radium-223 Product Picture
Figure 6. Holmium-166 Product Picture
Figure 7. Other Product Picture
Figure 8. Global Radiopharmaceutical Market Share by Application in 2020 & 2027
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Global Radiopharmaceutical Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Radiopharmaceutical Market Size 2016-2027 (US$ Million)
Figure 14. Global Radiopharmaceutical Sales 2016-2027 (M Doses)
Figure 15. Global Radiopharmaceutical Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Radiopharmaceutical Sales Share by Manufacturers in 2020
Figure 17. Global Radiopharmaceutical Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Radiopharmaceutical Players: Market Share by Revenue in 2020
Figure 19. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Radiopharmaceutical Sales Market Share by Region (2016-2021)
Figure 21. Global Radiopharmaceutical Sales Market Share by Region in 2020
Figure 22. Global Radiopharmaceutical Revenue Market Share by Region (2016-2021)
Figure 23. Global Radiopharmaceutical Revenue Market Share by Region in 2020
Figure 24. U.S. Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Radiopharmaceutical Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Radiopharmaceutical by Type (2016-2021)
Figure 49. Sales Market Share of Radiopharmaceutical by Application (2016-2021)
Figure 50. Sales Market Share of Radiopharmaceutical by Application in 2020
Figure 51. Revenue Share of Radiopharmaceutical by Application (2016-2021)
Figure 52. Revenue Share of Radiopharmaceutical by Application in 2020
Figure 53. Manufacturing Cost Structure of Radiopharmaceutical
Figure 54. Manufacturing Process Analysis of Radiopharmaceutical
Figure 55. Radiopharmaceutical Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed